1,328 participants aged 9–89 years received one of six vaccine types across three seasons (2022–2023–2024–2025). Serum samples were tested for hemagglutination inhibition (HAI) activity against vaccine and historical strains before and after vaccination. The dataset likely contains seroprotection and seroconversion rates analyzed by age group and vaccine platform.
Use Cases
- Compare antibody titers across six vaccine types based on vaccine platform data.
- Analyze seroconversion rates by age group based on participant age data.
- Study the effect of repeated annual vaccination on immune outcomes based on multi-season data.
- Evaluate hemagglutination inhibition (HAI) activity against historical strains based on back-boosting data.
Strengths
- 1,328 participants provide a substantial sample size.
- Data spans three consecutive seasons (2022–2023–2024–2025).
- Includes six distinct vaccine types for comparison.
- Measures antibody titers before and 28 days after vaccination.
Limitations
- Row count is unknown, which may limit suitability assessment.
- Column-level documentation is absent; field semantics must be inferred after download.
- The dataset is 190.3 KB, indicating a limited scope.
Provenance
- Source
- Engin Berber
- Collection Method
- Serum samples collected from participants and tested for HAI activity.
- Time Range
- 2022–2023–2024–2025
- Freshness
- Last updated 2026-04-16 17:37:38